
Ulrike Harjes and Laurence Zitvogel
Aug 11, 2025, 19:58
Ulrike Harjes: Laurence Zitvogel on Chemotherapy’s Role in Stimulating Anticancer Immunity
Ulrike Harjes, Senior Editor at Nature Medicine, shared a post on LinkedIn:
“In this Turning Point, a series of articles that Nature Medicine commissioned to celebrate its 30th anniversary, Laurence Zitvogel reflects on the contribution of her research on the induction of immunogenic cell death through conventional chemotherapy to today’s understanding and success of the stimulation of anticancer immune responses to treat patients with cancer.”
Title: Rethinking chemotherapy as an indirect vaccine
Journal: Nature Medicine
Authors: Laurence Zitvogel
More posts featuring Ulrike Harjes on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 11, 2025, 19:36
Aug 11, 2025, 19:28
Aug 11, 2025, 19:13
Aug 11, 2025, 19:08
Aug 11, 2025, 19:01
Aug 11, 2025, 18:54
Aug 11, 2025, 18:42